Alembic receives USFDA approval for olmesartan and hydrochlorothiazide
Alembic Pharmaceuticals has received final USFDA approval for two anti-hypertension tablets – olmesartan medoxomil tablets, 5 mg, 20 mg, and 40 mg and olmesartan medoxomil […]
Alembic
Alembic Pharma plans expansion programme at Panelav unit
Alembic Pharma is planning to expand its existing unit in Panelav village in Halol Tehsil in Panchmahal district of Gujarat. The project involves expanding active […]
Alembic Pharma receives USFDA approval for Zolmitriptan
Alembic Pharmaceuticals has received USFDA approval for Zolmitriptan Orally Disintegrating tablets, used for the treatment of migraine, in the American market. The product is therapeutically […]
Alembic Pharma receives USFDA approval for Telmisartan and Amlodipine
Alembic Pharmaceuticals has received USFDA approval for its Telmisartan and Amlodipine tablets in the strengths of 40mg/5 mg, 40mg/10 mg, 80mg/5 mg and 80mg/10 mg, […]
Alembic Pharma recieves USFDA approval for Lacosamide
Alembic Pharmaceuticals Ltd has received final USFDA approval for its Lacosamide tablets, which is indicated as adjunctive therapy in patients with partial onset seizures. The […]